JINZHEN for Treatment of Mild to Moderate COVID-19
Clinical trial NCT05092503 · COMPLETED
Trial details
- NCT number
- NCT05092503
- Sponsor
- Lianyungang Kanion Group, Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-26
- Primary completion
- 2023-05-12
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.